Stage-Specific Recovery Changes in the International Classification of Functioning Components Following Conservative Rehabilitation of Trigger Finger

• Sponsor: Hacettepe University (Other)
• Overall Status: Completed
• CT.gov ID: NCT05024617
• Collaborator: (none)
• Enrollment: 34
• Location: 1
• Actual Duration (Months): 6
• Patients Per Site Per Month: 5.7

Study Details

Study Description

Brief Summary

The aim of this study was to determine the effectiveness of conservative rehabilitation on the multi-dimensional health components based on WHO ICF model in Stage 1, Stage 2 and Stage 3 trigger finger and to determine the functional recovery patterns of each dimension during a three-month rehabilitation period. Thirty-four patients were participated in the study.

Condition or Disease	Intervention/Treatment	Phase
Trigger Finger	Other: conservative treatment

Study Design

• Study Type: Observational
• Actual Enrollment: 34 participants
• Observational Model: Cohort
• Time Perspective: Prospective
• Official Title: Stage-Specific Recovery Changes in the International Classification of Functioning Components Following Conservative Rehabilitation of Trigger Finger
• Actual Study Start Date: Mar 2, 2019
• Actual Primary Completion Date: May 20, 2019
• Actual Study Completion Date: Aug 31, 2019

Arms and Interventions

Arm

Intervention/Treatment

trigger finger stage 1-2-3 Volunteer patients between 35-65 years old diagnosed with Stage 1, Stage 2 and Stage 3 trigger finger based on the Froimson Classification were included in the study. Exclusion criteria include paediatric trigger finger, trigger thumb, concomitant de'Quervain tenosynovitis, carpal tunnel syndrome, or Dupuytren's contracture, neurological or rheumatological diseases, chronic pain syndromes, pregnancy and patients with treatment history of related finger/fingers

Other: conservative treatment; All patients had rehabilitation for a total of three months, including activity modification, splinting and exercises.

Outcome Measures

Primary Outcome Measures

1. Pain (VAS) [one month]

2. Number of triggering (ten active fist test / 30 second active fist test) [one month]

3. Grip strength (hand dynomometer and pinchmeter) [one month]

Eligibility Criteria

Criteria

• Ages Eligible for Study: 35 Years to 65 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: Yes

Inclusion Criteria:

• Diagnosed with Stage 1, Stage 2 and Stage 3 trigger finger based on the Froimson Classification

Exclusion Criteria:

• Paediatric trigger finger, trigger thumb, concomitant de'Quervain tenosynovitis, carpal tunnel syndrome, or Dupuytren's contracture, neurological or rheumatological diseases, chronic pain syndromes, pregnancy and patients with treatment history of related finger/fingers.

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	Hacettepe University Faculty of Physical Therapy and Rehabilitation	Ankara		Turkey

Sponsors and Collaborators

• Hacettepe University

Investigators

• Principal Investigator: Seda Namaldi, MSc, Hacettepe University, Faculty of Physical Therapy and Rehabilitation

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: Cigdem Ayhan, Associate Professor (Lecturer), Hacettepe University
• ClinicalTrials.gov Identifier: NCT05024617
• Other Study ID Numbers: 16969557-437
• First Posted: Aug 27, 2021
• Last Update Posted: Aug 27, 2021
• Last Verified: Aug 1, 2021

• Individual Participant Data (IPD) Sharing Statement: Undecided
• Plan to Share IPD: Undecided
• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Keywords provided by Cigdem Ayhan, Associate Professor (Lecturer), Hacettepe University: trigger finger; ICF; rehabilitation; splinting
• Additional relevant MeSH terms: Trigger Finger Disorder

Study Results

No Results Posted as of Aug 27, 2021